$CZNC

[Form 4] CITIZENS & NORTHERN CORP Insider Trading Activity

This article reports an insider trading activity for CITIZENS & NORTHERN CORP (CZNC), detailing a routine change in indirect ownership by executive vice president David S. Runk. The transaction involved the acquisition of 1 common stock share through dividend reinvestment in an employee stock ownership plan (ESOP), bringing his indirect holding to 65 common shares. The filing was deemed neutral in impact and sentiment.

Original reporting
Published May 22, 2026, 5:39 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 22, 2026, 6:00 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$CZNC
Neutral
high confidence
Mentioned
$CZNC · $CZNC
Relevance
6/10
AlphAI data visualization · based on Stock Titan
Decision brief

The 30-second read

$CZNCNeutralLow
01

Why it matters

The activity is minor and routine, with no expected impact on stock price or company fundamentals.

02

Market read

The insider activity has limited relevance to market movements and should not influence trading strategies.

03

What to watch

Market conditions and broader economic indicators are more relevant for trading decisions than this minor insider activity.

Relevance 6/10Timing: low

Background

This report details a routine insider transaction involving CITIZENS & NORTHERN CORP, where an executive increased indirect ownership through dividend reinvestment.

Company-level read

Ticker impact

$CZNCNeutralHigh confidence
Context

This insider activity involves a routine change in indirect ownership by an executive, with minimal impact on the stock's fundamentals.

Expected impact

No significant price movement expected in the near term.

Evidence & confidence

The transaction is routine, involving a small number of shares, and the overall sentiment is neutral, indicating limited influence on market perception.

$CZNCNeutralHigh confidence
Context

Same as above.

Expected impact

Likely negligible impact on stock price.

Evidence & confidence

Small transaction size and neutral sentiment imply minimal market reaction.

Market effects

Limited; the activity does not indicate sector-wide changes.

Minimal; specific to company insiders.

Negligible; routine insider activity.

Counterpoint

Some traders might interpret any insider activity as a potential signal, but in this case, the transaction is routine and unlikely to influence stock performance.

Key entities

  • David S. Runk

    Executive Vice President of CITIZENS & NORTHERN CORP

Related articles

$CZNCHigh

CITIZENS & NORTHERN CORP (CZNC): C&N ANNOUNCES RECORD QUARTERLY EARNINGS AND DECLARES INCREASE IN DIVIDEND

CITIZENS & NORTHERN CORP (CZNC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99 ​ ​ ​ Contact: Charity Frantz October 22, 2026 570-724-0225 charityf@cnbankpa.com ​ C&N ANNOUNCES RECORD QUARTERLY EARNINGS AND DECLARES INCREASE IN DIVIDEND ​ For Immediate Release: ​ Wellsboro, PA – Citizens & Northern Corporation (“C&N”) (NASDAQ: CZNC) announced its

$CZNCMed

CITIZENS & NORTHERN CORP (CZNC): C&N DECLARES DIVIDEND AND ANNOUNCES SECOND QUARTER 2026 UNAUDITED FINANCIAL RESULTS

CITIZENS & NORTHERN CORP (CZNC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99 2 cznc-20260723xex99.htm EX-99 Exhibit 99 ​ ​ Contact: Charity Frantz July 23, 2026 570-724-0225 charityf@cnbankpa.com ​ C&N DECLARES DIVIDEND AND ANNOUNCES SECOND QUARTER 2026 UNAUDITED FINANCIAL RESULTS For Immediate Release: ​ Wellsboro, PA – Citizens & Northern Corporat

$BAMed

Boeing 777F production reportedly halted for nearly two months by supplier dispute

Boeing 777F production halted for nearly two months due to a dispute with supplier Vaero over wing components, costing Boeing up to $6.5M per day. The 777F has 38 unfilled orders, with a backlog of about 31 aircraft. The FAA extended production through 2030, allowing up to 35 additional 777Fs. Boeing delivered 21 777Fs in 2026, with demand continuing despite the transition to the 777-8F.

$LLYMed

Eli Lilly And Company Presents First Clinical Data In Platinum-Sensitive Ovarian Cancer For Its Investigational, Next-Generation, FRa-Targeting ADC At ESMO 2026

Eli Lilly presented Phase 1 data for its investigational ADC sofetabart mipitecan (Sofe-M) plus bevacizumab in platinum-sensitive ovarian cancer, showing a 79% objective response rate and 100% disease control rate. The study included 33 patients, with responses consistent across prior treatments. Sofe-M demonstrated a safety profile consistent with known profiles of each medicine. The company is conducting three global Phase 3 trials for Sofe-M in ovarian cancer.